No profile data available.
Bruker Corporation (BRKR) is a healthcare company in the biological analysis equipment industry, based in Billerica, United States, with about 11,085 full-time employees.
It reported revenue of $3.44 billion for fiscal year 2025, up 2.1% from fiscal year 2024, and net income of -$22.50 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $838.50 million, up 5.2% from a year before. Its largest business segment, Bruker CALID, brought in 35% of segment revenue in fiscal year 2025; Europe Excluding Germany was the largest region with 28%. Its market capitalization was $8.96 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Bruker reported $3.44 billion in revenue for fiscal year 2025, up 2.1% from $3.37 billion in fiscal year 2024. In Q2 2026 revenue was $838.50 million.
Bruker CALID, with $1.21 billion or 35% of segment revenue in fiscal year 2025. Next: Bruker Nano (31%) and Bruker Bio Spin (26%).
Europe Excluding Germany: 28% of revenue by region in fiscal year 2025, followed by United States (26%).
$8.96 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Twist Bioscience Corporation (TWST), 10x Genomics, Inc. (TXG), Bio-Techne Corporation (TECH), Neogen Corporation (NEOG).